Detailed information for compound 1608381

Basic information

Technical information
  • TDR Targets ID: 1608381
  • Name: 5-(4-nitrophenyl)-4-[(4-nitrophenyl)methylide neamino]-2H-1,2,4-triazol-3-one
  • MW: 354.277 | Formula: C15H10N6O5
  • H donors: 1 H acceptors: 5 LogP: 2.33 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=c1[nH]nc(n1/N=C/c1ccc(cc1)[N+](=O)[O-])c1ccc(cc1)[N+](=O)[O-]
  • InChi: 1S/C15H10N6O5/c22-15-18-17-14(11-3-7-13(8-4-11)21(25)26)19(15)16-9-10-1-5-12(6-2-10)20(23)24/h1-9H,(H,18,22)/b16-9+
  • InChiKey: WQXQQZYSAJQZFY-CXUHLZMHSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-hydroxy-4-[4-[[4-(hydroxy-oxidoazaniumyl)phenyl]methylideneamino]-5-oxo-1H-1,2,4-triazol-3-yl]benzeneamine oxide
  • 4-[[4-(dihydroxyamino)phenyl]methylideneamino]-5-[4-(dioxidoamino)phenyl]-2H-1,2,4-triazol-3-one
  • 5-(4-nitrophenyl)-4-[(4-nitrophenyl)methyleneamino]-2H-1,2,4-triazol-3-one
  • N-hydroxy-4-[4-[[4-(hydroxy-oxido-ammonio)phenyl]methyleneamino]-5-oxo-1H-1,2,4-triazol-3-yl]benzeneamine oxide
  • 4-[[4-(dihydroxyamino)phenyl]methyleneamino]-5-[4-(dioxidoamino)phenyl]-2H-1,2,4-triazol-3-one
  • N-hydroxy-4-[4-[[4-(hydroxy-oxidoammonio)phenyl]methyleneamino]-5-oxo-1H-1,2,4-triazol-3-yl]benzeneamine oxide
  • 4-[(4-nitrobenzylidene)amino]-5-(4-nitrophenyl)-2H-1,2,4-triazol-3-one
  • N-hydroxy-4-[4-[[4-(hydroxy-oxido-ammonio)benzylidene]amino]-5-keto-1H-1,2,4-triazol-3-yl]benzeneamine oxide
  • 4-[[4-(dihydroxyamino)benzylidene]amino]-5-[4-(dioxidoamino)phenyl]-2H-1,2,4-triazol-3-one
  • N-hydroxy-4-[4-[[4-(hydroxy-oxido-azaniumyl)phenyl]methylideneamino]-5-oxo-1H-1,2,4-triazol-3-yl]benzeneamine oxide
  • NCI60_032527
  • 4-((4-(Hydroxy(oxido)amino)benzylidene)amino)-5-(4-(hydroxy(oxido)amino)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
  • AIDS-151154
  • AIDS151154
  • NSC690622

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trypanosoma cruzi Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2, putative 0.0181 0.253 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0028 0.0209 0.4722
Schistosoma mansoni protein kinase 0.0183 0.2563 0.2563
Echinococcus granulosus Vam6:Vps39 protein 0.0181 0.253 0.253
Brugia malayi Protein kinase domain containing protein 0.0183 0.2563 0.2811
Trypanosoma brucei phosphatidylinositol 4-kinase, putative 0.0044 0.0442 0.1749
Leishmania major target of rapamycin kinase (TOR) kinase 3 0.0035 0.0307 0.6934
Trichomonas vaginalis PIKK family atypical protein kinase 0.0032 0.0272 0.6145
Toxoplasma gondii target of rapamycin (TOR), putative 0.0032 0.0272 0.5
Brugia malayi hypothetical protein 0.0035 0.031 0.034
Onchocerca volvulus 0.0181 0.253 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0044 0.0442 1
Brugia malayi probable protein kinase 0.0613 0.912 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.0175 0.3945
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.0171 0.3855
Echinococcus granulosus FKBP12 rapamycin complex associated protein 0.0044 0.0442 0.0442
Trichomonas vaginalis PIKK family atypical protein kinase 0.0035 0.0306 0.6922
Echinococcus multilocularis 0.0432 0.6367 0.6367
Loa Loa (eye worm) STE/STE20/KHS protein kinase 0.0183 0.2563 0.2821
Echinococcus granulosus protein kinase 0.0432 0.6367 0.6367
Trichomonas vaginalis PIKK family atypical protein kinase 0.0024 0.0136 0.3078
Loa Loa (eye worm) phosphatidylinositol 3 0.0044 0.0442 0.0487
Brugia malayi Temporarily assigned gene name protein 59 0.0181 0.253 0.2774
Echinococcus multilocularis microtubule associated protein 2 0.0671 1 1
Schistosoma mansoni cellular tumor antigen P53 0.0048 0.0509 0.0509
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor2 0.0044 0.0442 0.1749
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0035 0.031 0.031
Schistosoma mansoni mitogen-activated protein kinase kinase kinase 3 mapkkk3 mekk3 0.0181 0.253 0.253
Echinococcus granulosus tumor protein p63 0.0328 0.4783 0.4783
Trichomonas vaginalis PIKK family atypical protein kinase 0.0032 0.0272 0.6145
Echinococcus multilocularis GTPase activating Rap:RanGAP domain 3 0.0181 0.253 0.253
Trypanosoma cruzi Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2, putative 0.0181 0.253 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0024 0.0136 0.3078
Trypanosoma brucei Phosphatidylinositol 3-kinase tor1 0.0044 0.0442 0.1749
Echinococcus multilocularis mitogen activated protein kinase kinase kinase 0.0183 0.2563 0.2563
Schistosoma mansoni protein kinase 0.0432 0.6367 0.6367
Trichomonas vaginalis PIKK family atypical protein kinase 0.0024 0.0136 0.3066
Trypanosoma brucei phosphatidylinositol 3-kinase tor, putative 0.0021 0.0092 0.0362
Echinococcus multilocularis tumor protein p63 0.0328 0.4783 0.4783
Schistosoma mansoni hypothetical protein 0.0181 0.253 0.253
Loa Loa (eye worm) hypothetical protein 0.0181 0.253 0.2784
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor1 0.0044 0.0442 0.1749
Trichomonas vaginalis PIKK family atypical protein kinase 0.0024 0.0136 0.3078
Trichomonas vaginalis PIKK family atypical protein kinase 0.0035 0.0306 0.6922
Echinococcus granulosus Serine/threonine-protein kinase Genghis Khan 0.0183 0.2563 0.2563
Trypanosoma cruzi target of rapamycin kinase 3 0.0035 0.0307 0.1213
Trichomonas vaginalis PIKK family atypical protein kinase 0.0035 0.0306 0.6922
Leishmania major target of rapamycin (TOR) kinase 1, putative 0.0044 0.0442 1
Schistosoma mansoni ataxia telangiectasia mutated (atm)-related 0.0044 0.0442 0.0442
Schistosoma mansoni rap gtpase-activating protein 0.0181 0.253 0.253
Schistosoma mansoni mitogen-activated protein kinase kinase kinase 3 mapkkk3 mekk3 0.0181 0.253 0.253
Trichomonas vaginalis PIKK family atypical protein kinase 0.0032 0.0272 0.6145
Trypanosoma brucei Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2, putative 0.0181 0.253 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0035 0.0306 0.6922
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.0171 0.3855
Trypanosoma brucei FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative 0.0018 0.0053 0.0211
Trichomonas vaginalis PIKK family atypical protein kinase 0.0044 0.0442 1
Echinococcus granulosus mitogen activated protein kinase kinase kinase 0.0183 0.2563 0.2563
Schistosoma mansoni serine/threonine protein kinase 0.0183 0.2563 0.2563
Trichomonas vaginalis PIKK family atypical protein kinase 0.0032 0.0272 0.6145
Loa Loa (eye worm) hypothetical protein 0.0048 0.0509 0.0561
Trichomonas vaginalis PIKK family atypical protein kinase 0.0024 0.0136 0.3066
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0044 0.0442 0.0485
Schistosoma mansoni vam6/vps39 related 0.0181 0.253 0.253
Brugia malayi hypothetical protein 0.0181 0.253 0.2774
Echinococcus granulosus GTPase activating Rap:RanGAP domain 3 0.0181 0.253 0.253
Trypanosoma brucei target of rapamycin kinase 3, putative 0.0035 0.0307 0.1213
Brugia malayi MH2 domain containing protein 0.0116 0.1545 0.1695
Schistosoma mansoni serine/threonine protein kinase 0.0183 0.2563 0.2563
Schistosoma mansoni hypothetical protein 0.0035 0.031 0.031
Loa Loa (eye worm) hypothetical protein 0.0611 0.9086 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0032 0.0272 0.6145
Echinococcus multilocularis FKBP12 rapamycin complex associated protein 0.0044 0.0442 0.0442
Trichomonas vaginalis PIKK family atypical protein kinase 0.0032 0.0272 0.6145
Trichomonas vaginalis PIKK family atypical protein kinase 0.0024 0.0136 0.3066
Trichomonas vaginalis PIKK family atypical protein kinase 0.0035 0.0306 0.6922
Entamoeba histolytica phosphatidylinositol3-kinaseTor2, putative 0.0044 0.0442 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.0175 0.3945
Loa Loa (eye worm) STE/STE20/MSN protein kinase 0.0432 0.6367 0.7007
Loa Loa (eye worm) hypothetical protein 0.0181 0.253 0.2784
Echinococcus multilocularis mitogen activated protein kinase kinase kinase 0.0183 0.2563 0.2563
Entamoeba histolytica FKBP-rapamycin associated protein (FRAP), putative 0.0044 0.0442 1
Schistosoma mansoni microtubule-associated protein tau 0.0671 1 1
Echinococcus multilocularis serine:threonine protein kinase MRCK beta 0.0183 0.2563 0.2563
Trichomonas vaginalis PIKK family atypical protein kinase 0.0029 0.0223 0.5047
Trichomonas vaginalis PIKK family atypical protein kinase 0.0032 0.0272 0.6145
Loa Loa (eye worm) transcription factor SMAD2 0.0116 0.1545 0.1701
Trichomonas vaginalis PIKK family atypical protein kinase 0.0024 0.0136 0.3078
Schistosoma mansoni protein kinase 0.0613 0.912 0.912
Loa Loa (eye worm) hypothetical protein 0.0181 0.253 0.2784
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0035 0.031 0.031
Trichomonas vaginalis PIKK family atypical protein kinase 0.0044 0.0442 1
Echinococcus granulosus serine:threonine protein kinase mig 15 0.0611 0.9086 0.9086
Trichomonas vaginalis PIKK family atypical protein kinase 0.0026 0.0175 0.3945
Schistosoma mansoni transcription factor LCR-F1 0.0035 0.031 0.031
Leishmania major target of rapamycin (TOR) kinase 2, putative 0.0044 0.0442 1
Loa Loa (eye worm) MH2 domain-containing protein 0.0116 0.1545 0.1701
Giardia lamblia GTOR 0.0044 0.0442 0.5
Echinococcus granulosus mitogen activated protein kinase kinase kinase 0.0183 0.2563 0.2563
Trichomonas vaginalis PIKK family atypical protein kinase 0.0037 0.0345 0.78

Activities

Activity type Activity value Assay description Source Reference
GI50 (functional) -4.517 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.315 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4.217 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) ChEMBL. No reference
GI50 (functional) -4 PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.